Shopping Cart
Remove All
Your shopping cart is currently empty
Sapelizumab is a humanised antibody targeting IL-6Ra/CD126, containing huIgG2-type heavy chains and huκ-type light chains, used as an IL-6 antagonist for neuromyelitis optica spectrum disorders (NMOSD).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $645 | - | In Stock | |
| 10 mg | $993 | - | In Stock | |
| 25 mg | $1,470 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock |
| Description | Sapelizumab is a humanised antibody targeting IL-6Ra/CD126, containing huIgG2-type heavy chains and huκ-type light chains, used as an IL-6 antagonist for neuromyelitis optica spectrum disorders (NMOSD). |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | IL-6 R alpha/CD126 |
| Molecular Weight | ~150 kDa |
| Isotype | Human IgG2 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.